compound semaglutide deaths Demand Rising for 'Bootlegged' Weight-Loss Drug Drugmakers battle pharmacies over compounded

doi: 10.1038/s41366-019-0513-y

The most common side effects across all these medications are: Gastrointestinal Nausea/vomiting These typically occur when starting treatment or increasing doses, and usually improve within the first few months

The Risks of Responding "Too Well" Being a super responder sounds like a win, but losing weight at an extreme speed carries medical risks

Most users never see the dysesthesia signal because community doses stay below 9 mg/week

If you qualify for existing medications tirzepatide (Zepbound, 22.5% average weight loss) or semaglutide (Wegovy, 14.9% average weight loss) the clinical case for waiting is weak